The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...

Leveraging the power of AI and machine learning technologies, researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug Administration (FDA) to treat adults with muscle-invasive bladder cancer ...

Cretostimogene monotherapy achieves a 75.5% complete response rate in high-risk, BCG-unresponsive non-muscle invasive bladder cancer patients. The treatment maintains a 46% complete response at 12 ...

ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common ... But it can involve surgery, radiotherapy, hormone therapy and chemotherapy.

Urothelial cancer occurs in the cells that form the inner lining of the bladder, urethra, ureter, or renal pelvis ... It is the first targeted treatment for unresectable (meaning it cannot be removed ...